Drug search by name

Metoclopramide Orally Disintegrating Tablets and Fluid retention

Result of checking the interaction of drug Metoclopramide Orally Disintegrating Tablets and disease Fluid retention for safety when used together.

Check result:

Metoclopramide Orally Disintegrating Tablets <> Fluid retention

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Metoclopramide produces a transient increase in plasma aldosterone and may cause fluid retention and volume overload in susceptible patients. Therapy with metoclopramide should be administered cautiously in patients with or at risk for fluid overload (e.g., cirrhosis, congestive heart failure). If these side effects occur at any time during metoclopramide therapy, the drug should be discontinued.

References:

"Product Information. Reglan (metoclopramide)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Ahmad S "Metoclopramide-induced acute congestive heart failure." South Med J 84 (1991): 283-4

Metoclopramide Orally Disintegrating Tablets

Generic Name: metoclopramide

Brand Name: Metozolv ODT, Reglan

Synonyms: Metoclopramide

What is Metoclopramide Orally Disintegrating Tablets?